Credit: ARS Pharmaceuticals. Neffy 1mg is expected to be available by the end of May 2025. For patients weighing 15kg to less than 30kg, the recommended dose is 1 spray of neffy 1mg. The Food and Drug ...

ARS Pharmaceuticals has announced the availability of neffy (epinephrine nasal spray) 1mg in the US, providing a new option for treating Type I allergic reactions, including anaphylaxis, in children ...

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi, an operating company of Fresenius, announced today that Epinephrine Injection, USP, is now available in the United States as the first generic ...

The availability of neffy 1 mg extends protection to younger, school-aged children—who make up nearly 23% of people needing epinephrine Visit neffy.com for savings and support programs and pay as ...

Credit: ARS Pharmaceuticals. Each carton contains 2 blister packages each with a single-dose nasal spray product for 1 time use. It is recommended that patients be prescribed and have immediate access ...

neffy 1 mg is the first approved needle-free epinephrine nasal spray for children aged 4 to 30 kg, addressing severe allergic reactions. ARS Pharmaceuticals announced the FDA approval of neffy 1 mg, ...

The US Food and Drug Administration (FDA) has approved ARS Pharmaceuticals' neffy 1mg (epinephrine nasal spray) for treating type one allergic reactions including anaphylaxis in paediatric patients ...

(RTTNews) - Amneal Pharmaceuticals, Inc. (AMRX) announced that the U.S. FDA has approved its Epinephrine injection USP, 1 mg/mL, in both single-dose and multi-dose for use in U.S. hospitals.

The U.S. Food and Drug Administration (FDA) has approved Richmond-based Kaléo’s supplemental drug application for the first epinephrine auto-injector specifically for infants and children with serious ...

First generic version of Epinephrine 1mg/1mL vial in U.S. market LAKE ZURICH, Ill., December 17, 2024--(BUSINESS WIRE)--Fresenius Kabi, an operating company of Fresenius, announced today that ...